An Observational Study of Dutasteride and Alpha-blocker Combination Therapy in Men With Symptomatic Benign Prostatic Hyperplasia and PSA Level Over 4 ng/mL
NCT01351987
·
clinicaltrials.gov ↗
UNKNOWN
Status
855
Enrollment
OTHER
Sponsor class
Conditions
Benign Prostatic Hyperplasia
Sponsor
Taipei Medical University WanFang Hospital